ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sunshine Biopharma Inc. - Warrant (NQ:SBFMW)

0.0611 UNCHANGED

Streaming Delayed Price Updated: 3:17 PM EDT, Jul 23, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	0.0611
Bid (Size)	0.0273 (5,100)
Ask (Size)	0.0597 (7,000)
Prev. Close	0.0611
Today's Range	0.0611 - 0.0611
52wk Range	0.0160 - 0.6498
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sunshine Biopharma Q2 Report Reveals Approximately 1,940% Increase In Cash & Cash Equivalents And 80% Decrease In Net Loss Within 6 Months ↗

August 08, 2022

Sunshine Biopharma, Inc. (NASDAQ: SBFM) (NASDAQ: SBFMW) announced that it has filed its 2022 second-quarter report with the Securities and Exchange Commission.

Via Benzinga

Sunshine Biopharma Reveals Potential Intellectual Property Position In Connection With Ongoing mRNA-As-Therapeutics-Agents Research ↗

April 26, 2022

Photo credit: Patent application by Nick Youngson CC BY-SA 3.0

Via Benzinga

Performance

YTD	-64.6%	-64.6%
1 Month	-32.0%	-32.0%
3 Month	-50.7%	-50.7%
6 Month	-60.1%	-60.1%
1 Year	-73.2%	-73.2%

More News

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells ↗

April 25, 2022

Via Benzinga

Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells ↗

April 06, 2022

Via Benzinga

Sunshine Biopharma, Inc. Announces Pricing of $8 Million Private Placement Priced At-the-Market ↗

March 14, 2022

Via Benzinga

Aegis Capital Corp. acted as Sole Bookrunner on an Uplist of an $8 Million Underwritten Public Offering for Sunshine Biopharma Inc. (NASDAQ: SBFM; SBFMW)

February 17, 2022

From Aegis Capital Corp.

Via AccessWire

Frequently Asked Questions

Is Sunshine Biopharma Inc. - Warrant publicly traded?

Yes, Sunshine Biopharma Inc. - Warrant is publicly traded.

What exchange does Sunshine Biopharma Inc. - Warrant trade on?

Sunshine Biopharma Inc. - Warrant trades on the Nasdaq Stock Market

What is the ticker symbol for Sunshine Biopharma Inc. - Warrant?

The ticker symbol for Sunshine Biopharma Inc. - Warrant is SBFMW on the Nasdaq Stock Market

What is the current price of Sunshine Biopharma Inc. - Warrant?

The current price of Sunshine Biopharma Inc. - Warrant is 0.0611

When was Sunshine Biopharma Inc. - Warrant last traded?

The last trade of Sunshine Biopharma Inc. - Warrant was at 07/23/26 03:17 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.